Abstract
Information management and the presence of dark data is the most alarming and vulnerable topic that needs to be addressed amidst the rapid growth of technology. The unused, untapped, or unstructured data in our archives can be called as dark data. Under the HIPPA regulations, the clinical data needs to be stored and secured for years, so the amount of dark data in healthcare databases consumes a large amount of storage space. The paper shows the comparative performance of the random forest algorithm with and without dark data from the patient’s health record for the early detection of Alzheimer’s disease. The model executes in two ways, (1) considering only the Alzheimer’s disease parameters and (2) including diabetes disease parameters which are considered as dark data for the Alzheimer’s disease. The results of the research work clearly say that utilizing the health dark data has increased the accuracy by 16.3% and hence helps in making better decisions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
V. Seehusen, E. Maldonado, Using a roadmap in the back alleys of dark data. J. Technol. Res. 9 (2020)
W. Su, Z. Cai, Y. Li, F. Liu, S. Fang, G. Wang, Data processing and text mining technologies on electronic medical records: a review. J. Health Care Eng. (2018)
W. Dimitrov, C. Cяpoвa, L. Petkova, Types of dark data and hidden cyber-security risks. Technical Report (2018). https://doi.org/10.13140/RG.2.2.31695.43681
https://developer.ibm.com/technologies/analytics/articles/ba-data-becomes-knowledge-3/
M. Tao, Clinical information extraction from unstructured free-texts. PhD thesis (Department of Information Science, University at Albany, 2018)
D. Friedman, L.S. Honig, N. Scarmeas, Seizures and epilepsy in Alzheimer’s disease. CNS NeuroSci. Ther. 18(4) (2012). https://doi.org/10.1111/j.1755-5949.2011.00251
M. Asadollahi, M. Atazadeh, M. Noroozian, Other Demen, seizure in Alzheimer’s disease: an underestimated phenomenon. Am J Alzheimers Dis. 34(2), 81–88 (2019). https://doi.org/10.1177/1533317518813551
A. Ott, M.M.B. Breteler, F. Van Harskamp, D.E. Grobbee, A. Hofman, Incidence of Alzheimer’s disease and vascular dementia in the Rotterdam study. 970–973 (1996). https://doi.org/10.1136/bmj.310.6985.970
A. Ott, R. Stolk, F. Van Harskamp, H. Pols, A. Hofman, M. Breteler, Diabetes mellitus and the risk of dementia: The Rotterdam study. Neurology 10, 1937–1942 (1999)
C.L. Leibson, W.A. Rocca, V.A. Hanson, R. Cha, E. Kokmen, P.C. O’Brien, P.J. Palumbo, The risk of dementia among persons with diabetes mellitus: a population-based cohort study. Ann N Y Acad Sci 826, 422–427 (1997)
R. Peila, B.L. Rodriguez, L.J. Launer, Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies—The Honolulu-Asia aging study. Diabetes 51, 1256–1262 (2002)
W.L. Xu, C.X. Qiu, A. Wahlin, B. Winblad, L. Fratiglioni, Diabetes mellitus and risk of dementia in the Kungsholmen project—A 6-year follow-up study. Neurology 63, 1181–1186 (2004)
M.A. Schilling, Unraveling Alzheimer’s: making sense of the relationship between diabetes and Alzheimer’s disease. J Alzheimer’s Dis. 51(4), 961–977 (2016). https://doi.org/10.3233/JAD-150980.PMID:26967215;PMCID:PMC4927856
N.R. Rajeshkanna, S. Valli, P. Thuvaragah, Relation between diabetes mellitus type 2 and cognitive impairment: a predictor of Alzheimer's disease. Int. J. Med. Res. Health Sci. 3(4), 903 (2014)
A.M. Ortiz Zuñiga, R. Simó, O. Rodriguez-Gómez, C. Hernández, A. Rodrigo, L. Jamilis, L. Campo, M. Alegret, M. Boada, A. Ciudin, Clinical applicability of the specific risk score of dementia in Type 2 diabetes in the identification of patients with early cognitive impairment: results of the MOPEAD study in Spain. J Clin Med. 9(9), 2726 (2020). https://doi.org/10.3390/jcm9092726.PMID:32847012;PMCID:PMC7565958
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this paper
Cite this paper
Maju, S.V., Gnana Prakasi, O.S. (2022). Utilization of Dark Data from Electronic Health Records for the Early Detection of Alzheimer’s Disease. In: Shetty D., P., Shetty, S. (eds) Recent Advances in Artificial Intelligence and Data Engineering. Advances in Intelligent Systems and Computing, vol 1386. Springer, Singapore. https://doi.org/10.1007/978-981-16-3342-3_16
Download citation
DOI: https://doi.org/10.1007/978-981-16-3342-3_16
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-16-3341-6
Online ISBN: 978-981-16-3342-3
eBook Packages: Intelligent Technologies and RoboticsIntelligent Technologies and Robotics (R0)